The expression of low density lipoprotein receptor-related protein in colorectal carcinoma

Oncology Reports

Volumn 17, Issue 2, 2007, Pages 361-367

  Obermeyer, Katrin ^a   Krueger, Sabine ^a   Peters, Brigitte ^a   Falkenberg, Bernd ^b   Roessner, Albert ^a   Röcken, Christoph ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Altmarkklinikum GmbH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cathepsin B; Colorectal carcinoma; Immunohistochemistry; Low densitiy lipoprotein receptor related protein; PCR; Urokinase type plasminogen activator

Indexed keywords

CATHEPSIN B; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; UROKINASE;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CANCER INVASION; CARCINOMA; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CATHEPSIN B; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; URINARY PLASMINOGEN ACTIVATOR;

EID: 33947726519     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.2.361     Document Type: Article

References (55)

1. Hamilton SR and Aalton LA (eds): World Health Organisation of Tumors. Pathology and Genetics of Tumors of the Digestive System. IARC Press, Lyon, pp103-146, 2000.
2. Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993. (Pubitemid 23065437)
3. Talieri M, Papadopoulou S, Scorilas A, Xynopoulos D, Arnogianaki N, Plataniotis G, Yotis J and Agnanti N: Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett 205: 97-106, 2004. (Pubitemid 38230144)
4. Grondahl-Hansen J, Ralfkiaer E, Kirkeby LT, Kristensen P, Lund LR and Dano K: Localisation of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 138: 111-117, 1991.
5. Kirschke H, Barrett AJ and Rawlings ND: Proteinases1: lysosomal cysteine proteinases. In: Protein Profile. Vol. 2. Sheterline P (ed). Academic Press, London, pp1587-1591, 1995.
6. Buck MR, Karustis DG, Day NA, Honn KV and Sloane BF: Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 282: 273-278, 1992.
7. Lah TT, Buck MR, Honn KV, Crissman JD, Nagesawa CR, Liotta LA and Sloane BF: Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis 7: 461-468, 1989. (Pubitemid 19114020)
8. Eeckhout Y and Vaes G: Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 166: 21-31, 1977. (Pubitemid 8127122)
9. Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Gunzler WA, Janicke F and Graeff H: Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem 266: 5147-5152, 1991. (Pubitemid 21909471)
10. Wang PH, Do YS, Macaulay L, Shinagawa T, Anderson PW, Baxter JD and Hsueh WA: Identification of renal cathepsin B as a human prorenin-processing enzyme. J Biol Chem 266: 12633-12638, 1991. (Pubitemid 21907142)
11. Sameni M, Elliott E, Ziegler G, Fortgens PH, Dennison C and Sloane BF: Cathepsin B and D are localized at the surface of human breast cancer cells. Pathol Oncol Res 1: 43-53, 1995.
12. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD and Honn KV: Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 83: 2483-2487, 1986. (Pubitemid 16026907)
13. Arkona C and Wiederanders B: Expression, subcellular distribution and plasma membrane binding of cathepsin B and gelatinases in bone metastatic tissue. Biol Chem 377: 695-702, 1996. (Pubitemid 26418094)
14. Werb Z, Banda MJ and Jones PA: Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 152: 1340-1357, 1980. (Pubitemid 11241633)
15. Murphy G, Ward R, Gavrilovic J and Atkinson S: Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1: S224-S230, 1992.
16. Skrzydlewska E, Sulkowska M, Koda M and Sulkowski S: Proteolytic- antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol 11: 1251-1266, 2005. (Pubitemid 40425906)
17. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L: Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44: 139-266, 1985.
18. Eaton DL, Scott RW and Baker JB: Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J Biol Chem 259: 6241-6247, 1984. (Pubitemid 14106337)
19. Petersen LC, Lund LR, Nielsen LS, Dano K and Skriver L: One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263: 11189-11195, 1988.
20. Blasi F, Vassalli JD and Dano K: Urokinase-type plasminogen activator: proenzyme, receptor and inhibitors. J Cell Biol 104: 801-804, 1987. (Pubitemid 17068652)
21. Kasai S, Arimura H, Nishida M and Suyama T: Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J Biol Chem 260: 12377-12381, 1985. (Pubitemid 16228415)
22. Cubellis MV, Nolli ML, Cassani G and Blasi F: Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J Biol Chem 261: 15819-15822, 1986. (Pubitemid 17202819)
23. Ellis V, Scully MF and Kakkar VV: Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study. J Biol Chem 262: 14998-15003, 1987. (Pubitemid 17160171)
24. Czekay RP, Kuemmel TA, Orlando RA and Farquhar MG: Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell 12: 1467-1479, 2001. (Pubitemid 33044425)
25. Herz J, Clouthier DE and Hammer RE: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation. Cell 71: 411-421, 1992.
26. Nykjaer A, Petersen CM, Moller B, Jensen PH, Moestrup SK, Holtet TJ, Etzerodt M, Thgersen HC, Munch M, Andreasen PA and Gliemann J: Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. J Biol Chem 267: 14543-14546, 1992.
27. Strickland DK, Kounnas MZ and Argraves WS: LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 9: 890-898, 1995.
28. Zhang JC, Sakthivel R, Kniss D, Graham CH, Strickland DK and McCrae KR: The low density lipoprotein receptor-related protein/α2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells. J Biol Chem 273: 32273-32280, 1998. (Pubitemid 29177174)
29. Stefansson S and Lawrence DA: The serpin PAI-1 inhibits cell migration by blocking integrin alpha v beta 3 binding to vitronectin. Nature 383: 441-443, 1996. (Pubitemid 26330833)
30. Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, Bartke I, Knapp W and Stockinger H: Urokinase plasminogen activator receptor, beta 2-integrins and Src-kinases within a single receptor complex of human monocytes. J Exp Med 181: 1381-1390, 1995.
31. Tarui T, Mazar AP, Cines DB and Takada Y: Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction. J Biol Chem 276: 3983-3990, 2001.
32. Nguyen DHD, Webb DJ, Catling AD, Song Q, Dhakephalkar A, Weber MJ, Ravichandran KS and Gonias SL: Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem 275: 19382-19388, 2000. (Pubitemid 30422913)
33. Sitrin RG, Pan PM, Harper HA, Blackwood RA and Todd RF III: Urokinase receptor (CD87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes. J Immunol 163: 6193-6200, 1999.
34. Webb DJ, Nguyen DHD and Gonias S: Extracellular signal-regulated functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and Matrigel invasion. J Cell Sci 113: 123-134, 2000. (Pubitemid 30066339)
35. Wittekind CH and Sobin LH: TNM Classification of Malignant Tumours. 6th edition. Wiley-Liss, Inc., 2002.
36. Boucher P and Gotthardt M: LRP and PDGF signaling: a pathway to atherosclerosis. Trends Cardiovasc Med 14: 55-60, 2004. (Pubitemid 38340847)
37. Herz J and Willnow TE: Functions of the LDL receptor gene family. Ann NY Acad Sci 737: 14-19, 1994. (Pubitemid 24316255)
38. Moestrup SK: The α2-macroglobulinreceptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochem Biophys Acta 1197: 197-213, 1994.
39. Moestrup SK, Kalthoft K, Petersen CM, Pedersen S, Gliemann J and Christensen EI: Immunocytochemical identification of the human α2-macroglobulin receptor in monocytes and fibroblasts: monoclonal antibodies define the receptor as a monocyte differentiation antigen. Exp Cell Res 190: 195-203, 1990.
40. Moestrup SK, Gliemann J and Pallesen G: Distribution of the α2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269: 375-382, 1992.
41. Herz J and Strickland DK: LRP: a multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784, 2001. (Pubitemid 32880284)
42. Brown MS, Herz J, Kowal RC and Goldstein JL: The low-density lipoprotein receptor-related protein: double agent or decoy? Curr Opin Lipid 2: 65-72, 1991. (Pubitemid 121001097)
43. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H and Stanley KK: Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J 7: 4119-4127, 1988.
44. Kowal RC, Herz J, Goldstein JL, Esser V and Brown MS: Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 86: 5810-5814, 1989. (Pubitemid 19217543)
45. Rohlmann A, Gotthardt M, Hammer RE and Herz J: Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101: 689-695, 1998. (Pubitemid 28084254)
46. Moestrup SK and Gliemann J: Purification of the rat hepatic α2-macroglobulin receptor as an approximately 440-kDa single chain protein. J Biol Chem 264: 15574-15577, 1989.
47. Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorni M and Argraves WS: Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265: 17401-17404, 1990.
48. Christensen L, Wiborg Simonsen AC, Heegard CW, Moestrup SK, Andersen JA and Andreasen PA: Immunohistochemical localisation of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66: 441-452, 1996.
49. De Vries TJ, Verheijen JH, De Bart AWC, Weidle UH, Ruiter DJ and van Muijen GNP: Decreased expression of both the lowdensity lipoprotein receptor-related protein/α2-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. Cancer Res 56: 1432-1439, 1996.
50. Desrosiers RR, Rivard ME, Grundy PE and Annabi B: Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors. Pediatr Blood Cancer 46: 40-49, 2006. (Pubitemid 41779316)
51. Kancha RK, Stearns ME and Hussain MM: Decreased expression of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor in invasive cell clones derives from human prostate and breast tumor cells. Oncol Res 6: 365-372, 1994. (Pubitemid 24371422)
52. Weaver AM, Hussaini IM, Mazar A, Henkin J and Gonias SL: Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem 272: 14372-14379, 1997. (Pubitemid 27232853)
53. Yamamoto M, Ikeda K, Ohshima K, Tsugu H, Kimura H and Tomonaga M: Increased expression of low density lipoprotein receptor-related protein/α2-macroglobulin receptor in human malignant astrocytomas. Cancer Res 57: 2799-2805, 1997. (Pubitemid 27283795)
54. Fabrizi C, Businaro R, Persichini T, Fumagalli L and Lauro GM: The expression of the LDL receptor-related protein (LRP) correlates with the differentiation of human neuroblastoma cells. Brain Res 776: 154-161, 1997. (Pubitemid 28018470)
55. Cavallo-Medved D, Mai J, Dosescu J, Sameni M and Sloane BF: Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cellsurface receptors in human colorectal carcinoma cells. J Cell Sci 118: 1493-1503, 2005. (Pubitemid 40585129)